BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28445271)

  • 1. Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy.
    Wang Y; Chen G
    Medicine (Baltimore); 2017 Apr; 96(17):e6692. PubMed ID: 28445271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
    Du XJ; Chen L; Li WF; Tang LL; Mao YP; Guo R; Sun Y; Lin AH; Ma J
    Head Neck; 2017 Mar; 39(3):492-497. PubMed ID: 27997061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era.
    Chen Z; Guo Q; Lu T; Lin S; Zong J; Zhan S; Xu L; Pan J
    Med Sci Monit; 2017 Jan; 23():437-445. PubMed ID: 28120819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma.
    Wan XB; Wei L; Li H; Dong M; Lin Q; Ma XK; Huang PY; Wen JY; Li X; Chen J; Ruan DY; Lin ZX; Chen ZH; Liu Q; Wu XY; Hong MH
    Eur J Cancer; 2013 Jul; 49(10):2356-64. PubMed ID: 23541571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
    Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
    PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Zhou GQ; Ren XY; Mao YP; Chen L; Sun Y; Liu LZ; Li L; Lin AH; Mai HQ; Ma J
    Sci Rep; 2016 Mar; 6():22326. PubMed ID: 26928265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis.
    Zhou GQ; Tang LL; Mao YP; Chen L; Li WF; Sun Y; Liu LZ; Li L; Lin AH; Ma J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e359-65. PubMed ID: 22000748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Li AC; Xiao WW; Wang L; Shen GZ; Xu AA; Cao YQ; Huang SM; Lin CG; Han F; Deng XW; Zhao C
    Tumour Biol; 2015 Nov; 36(11):8349-57. PubMed ID: 26014515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
    Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
    Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma.
    Ou D; Wang X; Wu M; Xue F; Li Y; Hu C; He X
    Strahlenther Onkol; 2020 Mar; 196(3):252-261. PubMed ID: 31701168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
    Zhang B; Hu Y; Xiong RH; Pan YF; Xu QL; Kong XY; Cai R; Chen QQ; Tang HY; Jiang W
    Oncotarget; 2017 Feb; 8(8):14078-14088. PubMed ID: 27845907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
    Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
    Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Ye L; Oei RW; Kong F; Xu T; Shen C; Wang X; He X; Kong L; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1309-1317. PubMed ID: 29589142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction Methotrexate, Cisplatin, and 5-Fluorouracil Versus Cisplatin and 5-Fluorouracil Followed by Radiotherapy in Pediatric Nasopharyngeal Carcinoma: A Retrospective Analysis in a Tertiary Cancer Center.
    Al Mousa A; Abu-Hijlih R; Salem A; Sultan I; Mula-Hussain L; Ismael T; Mohamad I
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e437-e442. PubMed ID: 28816803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.
    Cheng SH; Jian JJ; Tsai SY; Chan KY; Yen LK; Chu NM; Tan TD; Tsou MH; Huang AT
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):755-62. PubMed ID: 9652835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of pretreatment serum LDH and ALP levels on the prognosis of patients with nasopharyngeal carcinoma].
    Zhou JY; Chen T; Li W; Ye K; Wei ZB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(14):1069-1073. PubMed ID: 29798242
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wei Z; Zhang Z; Luo J; Li N; Peng X
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma.
    Li G; Gao J; Tao YL; Xu BQ; Tu ZW; Liu ZG; Zeng MS; Xia YF
    Chin J Cancer; 2012 Apr; 31(4):197-206. PubMed ID: 22237040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.